Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -5.06% | 150.00 | 0.0% | $678.53m | |
| AMGN | Amgen, Inc. | -0.35% | 249.70 | 1.5% | $585.90m | |
| GILD | Gilead Sciences, Inc. | -1.27% | 65.18 | 1.0% | $429.55m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.65% | 294.29 | 1.9% | $402.50m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.81% | 624.83 | 2.6% | $354.90m | |
| ILMN | Illumina, Inc. | -1.86% | 209.06 | 3.3% | $307.20m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 2.22% | 4.15 | 0.7% | $290.10m | |
| NVAX | Novavax, Inc. | -5.56% | 37.18 | 75.7% | $231.38m | |
| BIIB | Biogen, Inc. | -0.57% | 216.34 | 1.8% | $185.52m | |
| BNTX | BioNTech SE | -2.91% | 147.61 | 0.0% | $150.86m | |
| SAVA | Cassava Sciences, Inc. | 2.92% | 26.47 | 0.0% | $120.22m | |
| GOVX | GeoVax Labs, Inc. | -12.83% | 1.97 | 0.0% | $104.86m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.98% | 92.96 | 4.2% | $97.95m | |
| CRSP | CRISPR Therapeutics AG | 0.57% | 72.15 | 0.6% | $91.12m | |
| EXAS | EXACT Sciences Corp. | -2.73% | 38.48 | 17.6% | $84.05m |
Company Profile
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.